ketamine has been researched along with Malignant Melanoma in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holmfred, A | 1 |
| Waxler, B | 1 |
| Zhang, X | 1 |
| Wezeman, FH | 1 |
2 other studies available for ketamine and Malignant Melanoma
| Article | Year |
|---|---|
Failed intrathecal analgesia following severe, terminal cancer pain.
Topics: Amines; Analgesics; Anesthetics, Local; Back Pain; Bupivacaine; Catheterization; Clonidine; Cyclohex | 2004 |
Anesthetic agents modify tissue proteinase inhibitor content and tumor behavior.
Topics: Animals; Cell Division; Chromatography, High Pressure Liquid; Female; Halothane; Ketamine; Lung; Mal | 1994 |